Long-term survivors of childhood malignancies - Aeromedical dilemmas and implications

Aviation Space and Environmental Medicine

Volumn 77, Issue 12, 2006, Pages 1266-1270

  Landau, Dan Avi ^a,d   Azaria, Bella ^b   Fineman, Riva ^c   Barenboim, Erez ^a   Goldstein, Liav ^a  

^a ISRAELI AIR FORCE   (Israel)

^b IAF   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

^d Israel Aeromedical Center   (Israel)

Author keywords

Anthracycline toxicity; Childhood malignancy; Pilots; Second malignancy; Seizures in pilots

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; BLEOMYCIN; BUSULFAN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; MELPHALAN; METHOTREXATE; NITROSOUREA; TOPOTECAN; VINCRISTINE;

AEROSPACE MEDICINE; AIRPLANE CREW; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CARDIOMYOPATHY; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILDHOOD CANCER; EVALUATION; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; LUNG CANCER; LUNG DISEASE; LUNG FIBROSIS; LUNG INJURY; LUNG TOXICITY; MEDLINE; MORBIDITY; RADIATION DOSE; RADIATION INJURY; REVIEW; RISK FACTOR; SECOND CANCER; SEIZURE; SUDDEN DEATH; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW;

AEROSPACE MEDICINE; ANTINEOPLASTIC AGENTS; AVIATION; CHILD; HUMANS; NEOPLASMS; PERSONNEL SELECTION; RADIOTHERAPY; SURVIVORS;

EID: 33845431657     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Abid SH, Malhotra V, Perry MC. Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 2001; 13:242-8.
2. Arvidson J, Kihlgren M, Hall C, Lonnerholm G. Neuropsychological functioning after treatment for hematological malignancies in childhood, including autologous bone marrow transplantation. Pediatr Hematol Oncol 1999; 16:9-21.
3. Ballard T, Lagorio S, De Angelis G, Verdecchia A. Cancer incidence and mortality among flight personnel: a meta-analysis. Aviat Space Environ Med 2000; 71:216-24.
4. Band PR, Le ND, Fang R, et al. Cohort study of Air Canada pilots: mortality, cancer incidence, and leukemia risk. Am J Epidemiol 1996; 143:137-43.
5. Benoist MR, Lemerle J, Jean R, et al. Effects of pulmonary function of whole lung irradiation for Wilm's tumour in children. Thorax 1982; 37:175-80.
6. Bottomley SJ, Kassner E. Late effects of childhood cancer therapy. J Pediatr Nurs 2003; 18:126-33.
7. Condren M, Lubsch L, Vats TS. Long-term follow-up of survivors of childhood cancer. Indian J Pediatr 2005; 72:39-43.
8. Constine LS. What else don't we know about the late effects of radiation in patients treated for head and neck cancer? Int J Radiat Oncol Biol Phys 1995; 31:427-9.
9. Crom DB, Chathaway DK, Tolley EA, et al. Health status and health-related quality of life in long-term adult survivors of pediatric solid tumors. Int J Cancer Suppl 1999; 12:25-31.
10. Dahllof G, Jonsson A, Ulmner M, Huggare J. Orthodontic treatment in long-term survivors after pediatric bone marrow transplantation. Am J Orthod Dentofacial Orthop 2001; 120:459-65.
11. Duggal MS, Curzon ME, Bailey CC, et al. Dental parameters in the long-term survivors of childhood cancer compared with siblings. Oral Oncol 1997; 33:348-53.
12. Eiser C, Hill JJ, Vance YH. Examining the psychological consequences of surviving childhood cancer: systematic review as a research method in pediatric psychology. J Pediatr Psychol 2000; 25:449-60.
13. Evans SA, Cooke JN. Cardiac effects of anthracycline treatment and their implications for aeromedical certification. Aviat Space Environ Med 2003; 74:1003-8.
14. Fajardo LF, Stewart JR, Cohn KE. Morphology of radiation-induced heart disease: Arch Pathol 1968; 86:512-9.
15. Guibout C, Adjadj E, Rubino C, et al. Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol 2005; 23:197-204.
16. Gundestrup M, Storm HH. Radiation-induced acute myeloid leukemia and other cancers in commercial jet cockpit crew: a population-based cohort study. Lancet 1999; 354:2029-31.
17. Haldorsen T, Reitan JB, Tveten U. Cancer incidence among Norwegian airline pilots. Scand J Work Environ Health 2000; 26:106-11.
18. Hammal DM, Bell CL, Craft AW, Parker L. Second primary tumors in children and young adults in the North of England (1968-99). Pediatr Blood Cancer 2005; 45:155-61.
19. Hawkins MM. Second primary tumours among survivors of childhood cancer treated with anticancer drugs. IARC Sci Publ 1986; 231-52.
20. Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 1987; 56:339-47.
21. Hayakawa H, Komada Y, Hirayama M, et al. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer. Med Pediatr Oncol 2001; 37:4-9.
22. Hill JM, Kornblith AB, Jones D, et al. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer 1998; 82:208-18.
23. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002; 52:23-47.
24. Jenney ME. Malignant disease and the lung. Paediatr Respir Rev 2000; 1:279-86.
25. Kenney LB, Yasui Y, Inskip PD, et al. Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med 2004; 141:590-7.
26. Kremer LC, van Dalen EC, Offringa M, et al. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol 2001; 19:191-6.
27. Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 2004; 22:4979-90.
28. Langer T, Martus P, Ottensmeier H, et al. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Med Pediatr Oncol 2002; 38:320-8.
29. Legha SS, Benjamin RS, Mackay B, et al. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 1982; 96:133-9.
30. Lim MK. Cosmic rays: are air crew at risk? Occup Environ Med 2002; 59:428-32; discussion 432-3.
31. Lin HM, Teitell MA. Second malignancy after treatment of pediatric Hodgkin disease. J Pediatr Hematol Oncol 2005; 27:28-36.
32. Linnersjo A, Hammar N, Dammstrom BG, et al. Cancer incidence in airline cabin crew: experience from Sweden. Occup Environ Med 2003; 60:810-4.
33. Lipshultz SE, Lipsitz SR, Mone SM, et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 1995; 332:1738-43.
34. Maddrey AM, Bergeron JA, Lombardo ER, et al. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol 2005; 72:245-53.
35. Megdal SP, Kroenke CH, Laden F, et al. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 2005; 41:2023-32.
36. Mertens AC, Yasui Y, Liu Y, et al. Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study. Cancer 2002; 95:2431-41.
37. Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2001; 19:3163-72.
38. Moller TR, Garwicz S, Barlow L, et al. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol 2001; 19:3173-81.
39. Nakken KO, Solaas MH, Kjeldsen MJ, et al. Which seizure-precipitating factors do patients with epilepsy most frequently report? Epilepsy Behav 2005; 6:85-9.
40. National Cancer Institute. SEER Cancer Statistics Review 1975-2002. Bethesda, MD: National Cancer Institue; 2002.
41. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 2001; 93:618-29.
42. Oeffinger KC, Eshelman DA, Tomlinson GE, et al. Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting. Cancer 2000; 88:1687-95.
43. Olsen JH, Garwicz S, Hertz H, et al. Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ 1993; 307:1030-6.
44. Packer RJ, Gurney JG, Punyko JA, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol 2003; 21:3255-61.
45. Pinarli FG, Oguz A, Tunaoglu FS, et al. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy. Pediatr Blood Cancer 2005; 44:370-7.
46. Pratt CB, Ransom JL, Evans WE. Age-related adriamycin cardiotoxicity in children. Cancer Treat Rep 1978; 62:1381-5.
47. Prestor VV, Rakovec P, Kozelj M, Jereb B. Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood. Pediatr Hematol Oncol 2000; 17:527-40.
48. Pukkala E, Aspholm R, Auvinen A, et al. Cancer incidence among 10,211 airline pilots: a Nordic study. Aviat Space Environ Med 2003; 74:699-706.
49. Rafnsson V, Hrafnkelsson J, Tulinius H, et al. Risk factors for cutaneous malignant melanoma among aircrews and a random sample of the population. Occup Environ Med 2003; 60:815-20.
50. Rafnsson V, Sulem P, Tulinius H, Hrafnkelsson J. Breast cancer risk in airline cabin attendants: a nested case-control study in Iceland. Occup Environ Med 2003; 60:807-9.
51. Reynolds P, Cone J, Layefsky M, et al. Cancer incidence in California flight attendants (United States). Cancer Causes Control 2002; 13:317-24.
52. Schmitt K, Tulzer G, Merl M, et al. Early detection of doxorubicin and daunorubicin cardiotoxicity by echocardiography: diastolic versus systolic parameters. Eur J Pediatr 1995; 154:201-4.
53. Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Intern Med 1996; 125:47-58.
54. Smith PJ, Ekert H, Waters K, Matthews RN. High incidence of cardiomyopathy in children treated with adriamycin and DTIC in combination chemotherapy. Cancer Treat Rep 1977; 61:1736-8.
55. Steinherz L, Steinherz P. Delayed cardiac toxicity from anthracycline therapy. Pediatrician 1991; 18:49-52.
56. Steinherz LJ, Steinherz PG, Tan C. Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. Med Pediatr Oncol 1995; 24:352-61.
57. Steinherz LJ, Steinherz PG, Tan CT, et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991; 266:1672-7.
58. von der Weid N. Late effects in long-term survivors of ALL in childhood: experiences from the SPOG late effects study. Swiss Med Wkly 2001; 131:180-7.
59. Von Hoff DD, Rozencweig M, Piccart M. The cardiotoxicity of anticancer agents. Semin Oncol 1982; 9:23-33.
60. Wartenberg D, Stapleton CP. Risk of breast cancer is also increased among retired U.S. female airline cabin attendants. BMJ 1998; 316:1902.
61. Whelan EA. Cancer incidence in airline cabin crew. Occup Environ Med 2003; 60:805-6.
62. Whinnery JE, Whinnery AM. Acceleration-induced loss of consciousness. A review of 500 episodes. Arch Neurol 1990; 47:764-76.